Regenerx Biopharmaceuticals inc (RGRX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RGRX Annual Balance Sheets →
The table below presents a historical view of Regenerx Biopharmaceuticals inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2023)
(Dec 31 2022) (Sep 30 2022) (Jun 30 2022) (Mar 31 2022)
Assets
Cash & cash equivalent0.10
Cash & Short-term Investments0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current0.02
Total Current Assets0.12
Other Assets, Noncurrent0.06
Operating Lease Right Of Use Asset0.06
Total Assets0.19
Liabilities
Accounts Payable, Current AC0.04
Accrued Liabilities, Current AC0.47
Convertible Notes Payable, Current NO1.17
Other Liabilities, Current0.12
Total Current Liabilities1.80
Total Long-term Debt0.00
Other liabilities, Noncurrent2.13
Operating Lease Liability Current0.05
Contract With Customer Liability Noncurrent1.85
Total Liabilities3.93
Stockholders' Equity
Common Stock Value0.14
Additional Paid In Capital Common Stock108.71
Retained Earnings / Accumulated Deficit-112.60
Other Equity0.00
Common Stockholder's Equity-3.74
Total Stockholder's Equity-3.74
Liabilities & Stockholder's Equity0.19
4 historic quarters locked

Sign in to unlock the full Regenerx Biopharmaceuticals inc balance sheet history.

About Regenerx Biopharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001410578-23-001223

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.